Skip to main content

Table 1 Characteristics of the study population

From: Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients

 

Subgroups

p-value

 

A

B

B1

B2

A vs. B

B1 vs. B2

N

2049

131

106

25

  

 Age (years)

65.4 (8.2)

60.3 (10.0)

59.6 (9.9)

63.1 (10.2)

<.001a

.12a

  % Age < 45 years

1.0

3.8

3.8

4.0

<.001b

.63 b

  % Age 45–55 years

9.1

29.0

30.19

24.0

  

  % Age 56–65 years

33.6

29.8

31.1

24.0

  

  % Age 66–75 years

44.1

31.3

30.2

36.0

  

  % Age > 75 years

12.1

6.1

4.72

12.0

  

 Gender

  % Males

61.1

56.5

62.3

32.0

.30b

.01b

 COPD GOLD Grade

    

.01b

<.001b

  % Grade 1 (FEV1% pred. ≥ 80%)

9.0

4.6

4.7

4.0

  

  % Grade 2 (50 ≤ FEV1% pred. < 80)

42.3

34.4

24.5

76.0

  

  % Grade 3 (30 ≤ FEV1% pred. < 50)

38.1

42.8

50.9

8.0

  

  % Grade 4 (FEV1% pred. < 30)

10.5

18.3

19.8

12.0

  

 Education

    

<.001b

.86b

  % Basic school education

57.0

32.1

33.0

28.0

  

  % Secondary school education

26.0

43.5

42.5

48.0

  

  % Higher school education

17.0

24.4

24.5

24.0

  

 Smoking status

    

<.001b

.25b

  % Never smokers

5.4

23.7

20.8

36.0

  

  % Former smokers

69.2

75.6

78.3

64.0

  

  % Smokers

25.4

0.7

0.9

0.0

  

 BMI (kg/m2)

26.8 (5.3)

24.7 (4.0)

24.6 (4.1)

24.8 (3.6)

<.001a

.85a

  % Normal weight (18.5 ≤ BMI < 25)

35.7

52.7

52.8

52.0

<.001b

.64b

  % Overweight (25 ≤ BMI < 30)

37.1

33.6

32.1

40.0

  

  % Obese (BMI ≥ 30)

23.7

9.9

10.4

8.0

  

  % Underweight (BMI < 18.5)

3.5

3.8

4.7

0.0

  

 Comorbidities

      

  Count

3.9 (2.6)

3.1 (2.5)

3.0 (2.5)

3.4 (2.3)

<.001c

.30c

  % Liver cirrhosis

1.3

1.5

1.9

0.0

.68b

.49b

  % Hepatitis

5.4

6.9

8.5

0.0

.48b

.13b

  1. Data are mean (standard deviation) or percentage (%)
  2. A = COPD patients without Alpha-1-antitrypsin deficiency (AATD), B = COPD patients with AATD, B1 = COPD patients with AATD and augmentation therapy (AT), B2 = COPD patients with AATD but without AT
  3. a p-value based on t-test, b p-value based on Chi2-test, cWilcoxon signed rank test